ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/12/01 | 1,870 | 1,874 | 1,825 | 1,833 | -24 | -1.3% | 80,400 |
2016/11/30 | 1,846 | 1,858 | 1,829 | 1,857 | +11 | +0.6% | 123,800 |
2016/11/29 | 1,852 | 1,861 | 1,838 | 1,846 | -11 | -0.6% | 47,300 |
2016/11/28 | 1,855 | 1,863 | 1,845 | 1,857 | +4 | +0.2% | 65,800 |
2016/11/25 | 1,845 | 1,857 | 1,842 | 1,853 | +20 | +1.1% | 101,700 |
2016/11/24 | 1,870 | 1,870 | 1,831 | 1,833 | -27 | -1.5% | 62,300 |
2016/11/22 | 1,843 | 1,867 | 1,841 | 1,860 | +17 | +0.9% | 101,600 |
2016/11/21 | 1,830 | 1,860 | 1,830 | 1,843 | -2 | -0.1% | 105,500 |
2016/11/18 | 1,845 | 1,850 | 1,822 | 1,845 | -2 | -0.1% | 121,800 |
2016/11/17 | 1,830 | 1,850 | 1,827 | 1,847 | +7 | +0.4% | 124,600 |
2016/11/16 | 1,800 | 1,840 | 1,794 | 1,840 | +45 | +2.5% | 205,500 |
2016/11/15 | 1,780 | 1,799 | 1,769 | 1,795 | +23 | +1.3% | 129,600 |
2016/11/14 | 1,750 | 1,784 | 1,744 | 1,772 | +47 | +2.7% | 180,700 |
2016/11/11 | 1,740 | 1,754 | 1,718 | 1,725 | -5 | -0.3% | 117,300 |
2016/11/10 | 1,720 | 1,737 | 1,683 | 1,730 | +112 | +6.9% | 110,100 |
2016/11/09 | 1,703 | 1,720 | 1,604 | 1,618 | -72 | -4.3% | 126,500 |
2016/11/08 | 1,711 | 1,711 | 1,681 | 1,690 | -6 | -0.4% | 56,800 |
2016/11/07 | 1,737 | 1,737 | 1,681 | 1,696 | +26 | +1.6% | 125,800 |
2016/11/04 | 1,684 | 1,694 | 1,653 | 1,670 | -34 | -2% | 93,100 |
2016/11/02 | 1,744 | 1,744 | 1,692 | 1,704 | -52 | -3% | 87,000 |
2016/11/01 | 1,761 | 1,761 | 1,741 | 1,756 | -6 | -0.3% | 80,000 |
2016/10/31 | 1,734 | 1,767 | 1,708 | 1,762 | +20 | +1.1% | 195,000 |
2016/10/28 | 1,769 | 1,774 | 1,741 | 1,742 | -14 | -0.8% | 182,000 |
2016/10/27 | 1,767 | 1,767 | 1,738 | 1,756 | -5 | -0.3% | 86,400 |
2016/10/26 | 1,749 | 1,764 | 1,737 | 1,761 | +20 | +1.1% | 113,900 |
2016/10/25 | 1,751 | 1,753 | 1,738 | 1,741 | -8 | -0.5% | 80,000 |
2016/10/24 | 1,725 | 1,756 | 1,720 | 1,749 | +30 | +1.7% | 113,200 |
2016/10/21 | 1,729 | 1,729 | 1,715 | 1,719 | -5 | -0.3% | 79,300 |
2016/10/20 | 1,727 | 1,729 | 1,711 | 1,724 | -2 | -0.1% | 96,300 |
2016/10/19 | 1,734 | 1,739 | 1,721 | 1,726 | -8 | -0.5% | 58,400 |
2016/10/18 | 1,718 | 1,738 | 1,717 | 1,734 | +8 | +0.5% | 87,700 |
2016/10/17 | 1,728 | 1,731 | 1,707 | 1,726 | -10 | -0.6% | 82,000 |
2016/10/14 | 1,738 | 1,747 | 1,735 | 1,736 | -10 | -0.6% | 58,500 |
2016/10/13 | 1,745 | 1,746 | 1,719 | 1,746 | ±0 | ±0% | 65,600 |
2016/10/12 | 1,737 | 1,759 | 1,728 | 1,746 | -11 | -0.6% | 72,500 |
2016/10/11 | 1,757 | 1,759 | 1,744 | 1,757 | -5 | -0.3% | 74,800 |
2016/10/07 | 1,776 | 1,778 | 1,757 | 1,762 | -14 | -0.8% | 90,900 |
2016/10/06 | 1,780 | 1,787 | 1,772 | 1,776 | +3 | +0.2% | 135,800 |
2016/10/05 | 1,748 | 1,782 | 1,735 | 1,773 | +30 | +1.7% | 219,400 |
2016/10/04 | 1,735 | 1,750 | 1,708 | 1,743 | +13 | +0.8% | 149,700 |
2016/10/03 | 1,718 | 1,741 | 1,711 | 1,730 | +24 | +1.4% | 125,800 |
2016/09/30 | 1,677 | 1,715 | 1,669 | 1,706 | -10 | -0.6% | 109,500 |
2016/09/29 | 1,702 | 1,720 | 1,688 | 1,716 | +32 | +1.9% | 162,500 |
2016/09/28 | 1,682 | 1,687 | 1,544 | 1,684 | -32 | -1.9% | 176,700 |
2016/09/27 | 1,670 | 1,717 | 1,658 | 1,716 | +45 | +2.7% | 341,300 |
2016/09/26 | 1,675 | 1,690 | 1,668 | 1,671 | +1 | +0.1% | 126,300 |
2016/09/23 | 1,648 | 1,675 | 1,636 | 1,670 | +40 | +2.5% | 157,400 |
2016/09/21 | 1,610 | 1,631 | 1,602 | 1,630 | +22 | +1.4% | 135,200 |
2016/09/20 | 1,598 | 1,617 | 1,577 | 1,608 | +1 | +0.1% | 139,100 |
2016/09/16 | 1,598 | 1,607 | 1,580 | 1,607 | +25 | +1.6% | 146,600 |
1951~
2000
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,500円 | +13.6% | +29.2% | 2.04% | 11.70倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 474,500円 | +12.0% | +28.1% | 2.53% | 26.16倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,500円 | +197.7% | - | 0.00% | 46.38倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,800円 | +3.2% | +4.5% | 3.47% | 17.21倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム